期刊文献+

经动脉化疗栓塞兔VX2肝癌后早期肿瘤细胞凋亡 被引量:4

The Apoptosis of Tumor Cells in the Rabbit Model Bearing VX2 Liver Tumor during the Early Time after Transcatheter Arterial Chemoembolization
在线阅读 下载PDF
导出
摘要 目的 研究介入治疗兔VX2肝癌肿瘤细胞凋亡的早期动态改变 .方法 建立 2 7只新西兰大白兔VX2肝癌模型 ,随机分成肝动脉化疗栓塞组 (Transarterialchemoembolization ,TACE)、灌注化疗组 (Transarterialinfusion ,TAI)、灌注肝素生理盐水组 (对照组 ,Control) ,每组各 9只 .介入治疗后每组再随机分成 3个亚组 ,每亚组 3只 .在治疗后第2 4、72、12 0小时分别处死 3组中一亚组 ,取材肿瘤生长活跃的外带组织用流式细胞仪AnnexinV和PI双标记法定量检测细胞凋亡 ,组织病理切片苏木精 -伊红染色 (HE染色 )和甲基绿 -派洛宁染色 (MG -P染色 )光镜下形态学方法观察不同时间肿瘤细胞的凋亡变化 .结果 TACE、TAI、Control组在治疗后 2 4、72、12 0小时流式细胞仪法定量检测肿瘤细胞凋亡比率分别为 11.4 4± 2 .15、10 .99± 1.74、6 .0 0± 0 .5 8,5 .84± 0 .6 8、4 .6 5± 0 .11、2 .88± 1.2 3和 2 .80± 0 .15、2 .19± 1.6 9、2 .5 1± 2 .13.TACE、TAI、Control组凋亡在各时间点均有显著差异 (p <0 .0 1) ,TACE组 2 4、72小时的凋亡明显高于 12 0小时 (p <0 .0 5 ) .TACE组诱导的肿瘤细胞凋亡比率明显高于TAI、Control组 ;TACE组诱导的肿瘤细胞早期凋亡比率随时间呈下降趋势 ,在 12 0小时凋亡仍明显高于其? Objective To study the dynamic changes of apoptosis of tumor cells in the rabbit model bearing VX2 liver tumor during the early time after transarterial interventional. Methods 27 New Zealand white rabbits were implanted with VX2 tumor in the left lobe of the liver, then divided into 3 groups at random, TACE, TAI and Control, with 9 in each group. For 3 weeks after implanted with VX2 tumor, physiological saline, ADM and ADM-lipiodol were administrated via hepatic artery respectively in Control, TAI and TACE group which were divided into 3 subgroups respectively again at random according to the killing time: the 24 hours, the 72 hours, the 120 hours after treatment, 3 in each subgroup. Flow cytometry and microscope were used to observe the dynamic changes of the apoptosis of tumor cells in the margin of the tumor during the early time after transarterial interventional. Results Quantification assay of apoptosis measured by flow cytometry using Annexin V/PI double staining method indicated that the percentage of apoptosis cells accounted for 11.44±2.15, 10.99±1.74, 6.00±0.58 in TACE, 5.84±0.68, 4.65±0.11, 2.88±1.23 in TAI and 2.80±0.15, 2.19±1.69, 2.51±2.13 in Control respectively on the 1st, 3rd, 5th day after treatment. Significant difference between different groups in each time point was seen, and the apoptosis percentage both in the 24 hours and 72 hours time point was much higher than in the 120 hours in the TACE group. The apoptosis percentage in the TACE group was also much higher than in the TAI and Control groups, and dropped down along with time. Conclusions By inducing a large number of tumor cells apoptosis during the early time after treatment is one of the major mechanisms treating liver cancer by transarterial chemoembolization.
作者 全毅 陈胜利
出处 《现代临床医学生物工程学杂志》 2004年第6期460-464,共5页 Journal of Modern Clinical Medical Bioengineering
基金 硕士研究生课题
关键词 VX2肿瘤 肝肿瘤 动物模型 放射学 介入性 细胞凋亡 流式细胞术 VX2 neoplasm Liver neoplasm Animal model Rabbits Chemoembolization Therapeutic Radiology interventional Apoptosis Flow cytometry
  • 相关文献

参考文献5

二级参考文献58

  • 1Kuszyk BS, Bluemke DA, Choti MA, Contrast - enhanced CT of small hypovascular hepatic tumors:effect of lesion enhancement on conspicuity in rabbits [J]. AJR, 2000,174(2):471.
  • 2Lee FT, Chosy SG, Naidu SG, et al . CT depiction of experimental liver tumors: contrast enhancement with hepatecyte - selective iodinated triglyceride versus conventional techniques[J]. Radiology, 1997,203(2):465.
  • 3Geschwind JF, Artemov D, Abraham S,et al. Chemocmbolization of liver tumor in a rabbit model: assesamont of tumor cell death with diffusion-weighted MR imaging and histologic analysis[J]. J Vasc Interv Radiol,.2000,11(10):1245.
  • 4Sayesh Y, Poehon S, Vallee JP, et al. Detection of experimental hepatic tumors using long circulsting superparamagnetic particles[ J]. Invest Radiol,2001,36(1) : 15.
  • 5Liu JB, Goldberg BB, Merton DA, et al. The role of contrast -enhanced sonography for radiofrequency ablation of liver tumors[ J ]. J Ultrasound Med ,2001,20(5) :517.
  • 6Oya N, Nagata Y, Tamaki N, et al. FDG - PET evaluation of therapeutic effects on VX2 liver tumor[ J ]. J Nucl Med, 1996,37(2) : 296.
  • 7Kuwata Y, Hirota S, Sako M. Treatment of metastatic liver tumors by intermittent repetitive injection of an angiogenesis inhibitor using an implantable port system in a rabbit model[J]. Kobe J Med Sci. 1997.43(2) :83.
  • 8Tanaka H, Taniguehi H, Mugitani T, et el. Intra - arterial administration of the angiogenesis inhibitor TNP - 470 blocks liver metastasis in a rabbit model[J]. Br J Cancer, 1995,72(3) :650.
  • 9Eda I, Soga H, Ueoka M, Okada A, The suppression of postoperative liver metastasis caused by the continuous intraportal infusion of angiogenesis inhibitor FR - 118487 in a rabbit colon cancer model[J]. Stag Today, 1998,28(3) :273.
  • 10Thorstensen O, Isberg B, Svahn U, Jorulf H. Experimental tissue transplantation using a biopsy instrument and radiologic methods[J]. Invest Radiol 1994 Apt;29(4) :469.

共引文献51

同被引文献37

  • 1董兵超,邱霖,周旭欣,袁支润.推注时相及位置对支气管动脉灌注影响的模拟实验研究[J].四川大学学报(工程科学版),2005,37(1):24-28. 被引量:6
  • 2李向军,刘玉锋.细胞凋亡及检测方法[J].动物科学与动物医学,2004,21(12):30-32. 被引量:4
  • 3刘振堂,郭万亮,戴社教,张大鲲,胡洪兵,周斌,毛继刚,史步进,陈凯,程丽丽,张亚红,李迎春,牛风枝.兔肝血管插管技术及兔VX_2肝癌超声、DSA表现的实验研究[J].实用放射学杂志,2005,21(2):113-116. 被引量:5
  • 4谢喜平,林和官.福建黄兔泌乳性能初探[J].福建畜牧兽医,1996,18(3):7-9. 被引量:2
  • 5方太忠,王峰.血管内导管药盒系统置入术后并发症临床分析[J].介入放射学杂志,2007,16(7):491-492. 被引量:3
  • 6Shimizu E, Nakamura Y, Mukai J, et al. Parmacokinetics of bron chial artery infusion of mitomydn in patients with non-small cell lung cancer[J]. Omcer, 1991, 27(8) : 1046-1048.
  • 7Knebel P, Fimher L, Cremonese E, et al. Protocol of an expertim based randomized trial comparing surgical Venae Sectio versus radiological Puncture of Verm Subclavia for insertion of Totally Implantable Access Port inoncological patients[J].Trials, 2008, 9: 60.
  • 8Cheung E, Baerlocher MO, Asch M, et al. Venous access: A practical review for 2009[J].Can Faro Physidan, 2009,55 (5) 494-496.
  • 9Edwards MG, Anderson RM, Yuan M, et al. Gene expression profiling of aging reveals activation of a p53-mediated transcriptional progranl[J].BMC Genomics, 2007,8 : 80.
  • 10Yokouchi H, Yamazaki K, Kinoshita I, et al. Clinical benefit of readministration of gefitinib for initial gefitinilyresponders with non- small cell lung cancer[J]. BMC Cancer, 2007,20 (7) :51.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部